Binghamton University joins groundbreaking $42.8 million project on treating inflammatory diseases
Binghamton University will play a key role in a federal grant of up to $42.8 million to develop an implantable device that acts like a living pharmacy to treat inflammatory diseases. The Mayo Clinic is the preferred site for this groundbreaking research, and Binghamton researchers will help bioengineer the transplanted cells. The research is supported … Read more
